Pursuant to Regulation 30 and 33 of the SEBI (LODR) Regulations, 2015 we wish to inform that the board of directors at its meeting held tuesday 11th November, 2025 has inter alia considered and approved (1) unaudited standalone and consolidated financial results for the quarter ended 30th September, 2025 alongwith the limited review report (2) Appointment of CS Chaitra Arora (M.No. A78376) as Company Secretary & compliance officer and noted the resignation of CS siddhi shah (M. No. A44885) (3) Alteration of main object clause of the Memorandum of association to include manufacturing and trading of plastic and packaging materials subject to shareholders'' approval via postal ballot (4) Approval of postal ballot notice, calendar of events, cut- off date of 7th November, 2025 and appointment of Mr. Chintan K. Patel as a Scrutinizer.
Financial Results For The Quarter Ended 30Th September, 2025
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Earlier from Vivanza Biosciences
- Board Meeting Outcome for The Board Meeting Held On 11Th November, 2025
- Vivanza Biosciences Ltd. Press Release Nov 03 2025
- Board Meeting Intimation for Notice For The Meeting Of The Board Of Directors Pursuant To Regulation 29 And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Vivanza Biosciences Ltd. Press Release Oct 06 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Vivanza Biosciences
- Postal Ballot For Alteration Of The Main Object Clause Of The Memorandum Of Association Of The Company
- Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Non-Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Quarter And Half Year Ended On 30Th September, 2025
- Vivanza Biosciences Ltd. Press Release Nov 11 2025
- Results - Financial Results For 30Th September, 2025
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences